TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING RESEARCH & DEVELOPMENT EXPENDITURE
4.2.2 RISING DRUG DEVELOPMENT OUTSOURCING
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES AND COSTS ASSOCIATED TO DRUG DISCOVERY
4.4 OPPORTUNITY
4.4.1 TECHNOLOGICAL ADVANCEMENTS IN DRUG DISCOVERY
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
5.1.2 SERVICE CUSTOMIZATION
5.1.2.1 R&D
5.1.2.2 GOOD LABORATORY PRACTICES (GLP)
5.1.3 CUSTOMER PURCHASE SUPPORT
5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT ON THE DRUG DISCOVERY SERVICES MARKET
5.3.1 IMPACT ON R&D
5.3.2 IMPACT ON PRICING
5.3.3 IMPACT ON MARKET GROWTH
6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE
6.1 OVERVIEW
6.2 SMALL MOLECULE DRUG
6.3 BIOLOGICS DRUG
7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES
7.1 OVERVIEW
7.2 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
7.3 PHARMACEUTICAL SERVICES
7.4 MEDICINAL CHEMISTRY
7.5 BIOLOGICAL SERVICES
7.6 MEDICATION
8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 CARDIOVASCULAR DISEASES
8.4 RESPIRATORY DISEASES
8.5 DIABETES
8.6 OTHERS
9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 HIGH THROUGHPUT SCREENING
9.3 BIOCHIPS
9.4 PHARMACOGENOMICS AND PHARMACOGENETICS
9.5 METABOLOMICS
9.6 OTHERS
10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 RESEARCH & ACADEMIC INSTITUTES
10.4 OTHERS
11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN DRUG DISCOVERY SERVICES MARKET
12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DRUG DISCOVERY SERVICES MARKET
12.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.5.1 SERVICE LAUNCH
12.5.2 MERGERS & ACQUISITIONS
12.5.3 PARTNERSHIP/COLLABORATION
12.6 MAJOR PLAYERS SALES ANALYSIS
12.6.1 SALES & OPERATING INCOME, 2021 (USD MILLION)
12.6.2 MAJOR PLAYERS R&D ANALYSIS, 2021 (USD MILLION)
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ARAGEN LIFE SCIENCES PVT. LTD.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 KEY STRATEGIES
13.3 PIRAMAL PHARMA SOLUTIONS
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 CURIA GLOBAL, INC.
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 SERVICES OFFERED
13.4.4 KEY STRATEGIES
13.5 CHARLES RIVER LABORATORIES
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 EUROFINS SCIENTIFIC
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 IQVIA
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 EVOTEC
13.8.1 COMPANY OVERVIEWS
13.8.2 FINANCIAL OVERVIEW
13.8.3 SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 KEY STRATEGIES
13.9 WUXI APPTEC CO., LTD.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
13.10.1 COMPANY OVERVIEW
13.10.1 FINANCIAL OVERVIEW
13.10.2 SERVICES OFFERED
13.10.3 KEY DEVELOPMENTS
13.10.4 KEY STRATEGIES
13.11 SELVITA
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 SERVICES OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 SWOT ANALYSIS
13.11.6 KEY STRATEGIES
13.12 SYGNATURE DISCOVERY
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL OVERVIEW
13.12.3 SERVICES OFFERED
13.12.4 KEY DEVELOPMENTS
13.12.5 SWOT ANALYSIS
13.12.6 KEY STRATEGIES
13.13 SYMERES
13.13.1 COMPANY OVERVIEW
13.13.2 FINANCIAL OVERVIEW
13.13.3 SERVICES OFFERED
13.13.4 KEY DEVELOPMENTS
13.13.5 SWOT ANALYSIS
13.13.6 KEY STRATEGIES
13.14 NUCHEM SCIENCES INC.
13.14.1 COMPANY OVERVIEW
13.14.2 FINANCIAL OVERVIEW
13.14.3 SERVICES OFFERED
13.14.4 KEY STRATEGIES
13.15 PARAZA PHARMA, INC.
13.15.1 COMPANY OVERVIEW
13.15.2 FINANCIAL OVERVIEW
13.15.3 SERVICES OFFERED
13.15.4 KEY DEVELOPMENTS
13.15.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR SMALL MOLECULE DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICS DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 7 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 8 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICINAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICAL SERVICES, BY ERGION, 2023-2030 (USD MILLION)
TABLE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION)
TABLE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
TABLE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DIABETES, BY REGION, 2023-2030 (USD MILLION)
TABLE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR HIGH THROUGHPUT SCREENING COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOCHIPS, BY REGION, 2023-2030 (USD MILLION)
TABLE 21 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACOGENOMICS AND PHARMACOGENETICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 22 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR METABOLOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 23 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 24 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR END USER, BY REGION, 2023-2030 (USD MILLION)
TABLE 25 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 26 LOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 27 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 28 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 29 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 35 US: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 36 US: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 37 US: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 38 US: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 39 US: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 40 CANADA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 41 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 42 CANADA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 43 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 44 CANADA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 45 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 47 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 48 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 49 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 50 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 51 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 52 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 53 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 54 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 55 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 56 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 57 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 58 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 59 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 60 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 61 UK: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 62 UK: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 63 UK: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 64 UK: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 65 UK: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 66 ITALY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 67 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 68 ITALY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 69 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 70 ITALY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 71 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 72 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 73 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 74 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 75 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 76 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 77 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 78 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 79 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 80 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 87 CHINA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 88 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 89 CHINA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 90 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 91 CHINA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 92 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 93 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 94 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 95 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 96 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 97 INDIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 98 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 99 INDIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 100 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 101 INDIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 102 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 103 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 104 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 105 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 106 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 107 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 108 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 109 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 110 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 111 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 116 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 117 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 118 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 119 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 120 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 121 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 122 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 123 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 124 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 125 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 126 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 127 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 128 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 129 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 130 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 131 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 132 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 133 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 134 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 135 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 136 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 137 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 138 MAJOR MANUFACTURERS IN DRUG DISCOVERY SERVICES MARKET
TABLE 139 MOST ACTIVE PLAYER IN DRUG DISCOVERY SERVICES MARKET
TABLE 140 SERVICE LAUNCH
TABLE 141 MERGERS & ACQUISITIONS
TABLE 142 PARTNERSHIP/COLLABORATION
TABLE 143 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED
TABLE 144 ARAGEN LIFE SCIENCES PVT. LTD.: SERVICES OFFERED
TABLE 145 ARAGEN LIFE SCIENCES PVT.: KEY DEVELOPMENTS
TABLE 146 PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED
TABLE 147 CURIA GLOBAL, INC.: SERVICES OFFERED
TABLE 148 CURIA GLOBAL, INC.: KEY DEVELOPMENTS
TABLE 149 CHARLES RIVER LABORATORIES: SERVICES OFFERED
TABLE 150 CHARLES RIVER LABORATORIES: KEY DEVELOPMENTS
TABLE 151 EUROFINS SCIENTIFIC: SERVICES OFFERED
TABLE 152 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS
TABLE 153 IQVIA: SERVICES OFFERED
TABLE 154 EVOTEC: SERVICES OFFERED
TABLE 155 EVOTEC: KEY DEVELOPMENTS
TABLE 156 WUXI APPTEC CO., LTD.: SERVICES OFFERED
TABLE 157 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS
TABLE 158 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
TABLE 159 SELVITA: SERVICES OFFERED
TABLE 160 SELVITA: KEY DEVELOPMENTS
TABLE 161 SYGNATURE DISCOVERY: SERVICES OFFERED
TABLE 162 SYGNATURE DISCOVERY: KEY DEVELOPMENTS
TABLE 163 SYMERES: SERVICES OFFERED
TABLE 164 SYMERES: KEY DEVELOPMENTS
TABLE 165 NUCHEM SCIENCES INC.: SERVICES OFFERED
TABLE 166 NUCHEM SCIENCES INC.: KEY DEVELOPMENTS
TABLE 167 PARAZA PHARMA, INC.: SERVICES OFFERED
| ※参考情報 創薬サービスは、新しい医薬品の発見と開発を支援するための各種サービスを提供する業界の一部です。これらのサービスは、医薬品候補の探索から臨床試験の実施まで、幅広いプロセスを包含しています。創薬は非常に複雑で高コストなプロセスであり、その過程において専門的な知識と最新の技術が要求されるため、多くの企業や研究機関が創薬サービスを利用しています。 創薬サービスは大きく分けていくつかの種類があります。一つは前臨床研究サービスです。これは、候補薬の生物活性や安全性を評価するために、動物モデルや細胞ベースのシステムを用いた実験を行うことを含みます。前臨床研究は、候補化合物の効果を確認するための重要な段階であり、これにより最終的な臨床試験が適切な候補に対して行えるかどうかが決まります。 次に、臨床試験サービスがあります。これは新薬の安全性や効果を評価するために行われる人を対象とした研究で、通常は第I相から第III相までの段階に分かれています。第I相では主に安全性が、第II相では効果が、第III相では大規模な集団を対象にした比較検証が行われます。臨床試験は、新薬が市場に出る前に重要なデータを収集する機会であり、その結果が製薬会社の将来に大きな影響を与えます。 さらに、合成化学サービスも重要な役割を果たします。薬物候補を合成するためには、化合物の設計や合成の専門知識が必要です。合成化学サービスは、効率的で高品質な医薬品の合成を可能にします。また、高スループットスクリーニング（HTS）技術を利用して、大量の化合物ライブラリから特定の生物活性を示す化合物を迅速に特定することも行います。 バイオアッセイ開発サービスも創薬サービスの一環です。バイオアッセイは、活性化合物を用いることでその機能や効果を評価する技術です。これにより、候補薬の効能を測定し、最も有望な候補を選別することが可能になります。このようにして選別された候補は、さらに詳細な研究が行われ、開発が進められます。 創薬サービスの用途は多岐にわたります。特に、癌、神経疾患、感染症などの疾患に対する新しい治療法を探索するために利用されます。また、疾患モデルの開発にも用いられ、これにより新薬開発の効率を高めることができます。加えて、創薬サービスは医薬品市場の変動に合わせて、新たなニーズに応じた製品開発の加速化にも寄与しています。 関連技術としては、バイオインフォマティクスやシステムバイオロジーなどがあります。バイオインフォマティクスは、生物学的データを解析し、創薬に役立てる技術で、特に遺伝子解析や蛋白質構造の解析において重要な役割を果たしています。システムバイオロジーは、生物の複雑な相互作用をモデル化する技術であり、新薬の作用メカニズムの理解を深めます。 最近では、人工知能（AI）や機械学習も創薬プロセスにおいて重要な役割を果たしています。これらの技術はデータ解析の効率を向上させ、予測モデルを構築することで、薬剤候補の特定や最適化を迅速に行えるようにします。これにより、従来の手法では見逃されていたような新しい候補化合物を見つけることが可能になりました。 これらの創薬サービスと関連技術は、医療の進歩を加速させ、より効果的な治療法を提供するための基盤を築いています。特に、急激に進化する生物医学の分野では、創薬サービスが果たす役割はますます重要になりつつあります。今後も新たな技術が登場し、創薬プロセスが効率化されていくことが期待されています。これにより、患者への新薬の提供がよりスムーズになり、多くの人々が恩恵を受けることになるでしょう。 |
